Nelvir Tablet

Nelfinavir
150mg
Cipla Ltd.
Pack size 1
Dispensing mode
Source
Agent
Retail Price

Indications

Nelvir Tablet is used for: HIV infection

Adult Dose

Oral HIV infection Adult: Combined with other antiretrovirals: 1.25 g bid or 0.75 g tid. Hepatic Impairment Mild impairment (Child-Pugh class A): Dose adjustment not necessary Severe impairment (Child-Pugh Class B or C): Not recommended

Child Dose

Oral HIV infection Child: Combined with other antiretrovirals: 2-13 yr: 45-55 mg/kg bid or 25-35 mg/kg tid. Max: 0.75 g tid. Max Dosage: Child: 0.75 g tid.

Renal Dose

Renal Impairment Dose adjustment not necessary

Administration

Should be taken with food.

Contra Indications

Hypersensitivity; lactation.

Precautions

Pregnancy. Hepatic and renal impairment; haemophilia A or B; diabetes. Monitor for signs of lipodystrophy. Lactation: HIV+ women are advised not to breastfeed

Pregnancy-Lactation

Interactions

Reduced levels/effects with antacids, phenobarbital, carbamazepine, aminoglutethimide, phenytoin, rifampicin, nafcillin, nevirapine, omeprazole, nevirapine. Increased serum levels/effects with azole antifungal agents, cimetidine, efavirenz. Increased serum levels/effects of azithromycin, calcium channel blockers, clarithromycin, corticosteroids (e.g. fluticasone), mirtazapine, nateglinide, nefazodone, ciclosporin, sirolimus, tacrolimus, venlafaxine, eplerinone, fentanyl, atorvastatin, phosphodiesterase-5 (PDE-5) inhibitors, rifabutin, trazodone, TCAs. Reduced serum levels/effects of hormonal contraceptives, methadone, theophylline derivatives. Potentially Fatal: Increased serum levels/toxicity of amiodarone, cisapride, pimozide, midazolam, triazolam, ergot alkaloids, lovastatin, simvastatin, quinidine.

Adverse Effects

Side effects of Nelfinavir : >10% Diarrhea (14-20%) 1-10% Nausea (3-7%),Flatulence (1-5%),Abdominal pain (1%),Anemia (1%),Allergic reaction (1%),Impaired concentration (1%),Lipodystrophy (1%),Metabolic acidosis (1%),Rash (1-3%),Leukopenia (1%),Thrombocytopenia (1%),Weakness (1%) <1% QTc prolongation,Torsades de pointes,Diabetes mellitus, new onset and exacerbation,Hyperglycemia

Mechanism of Action

Nelfinavir is a selective, competitive, reversible HIV protease inhibitor. It inhibits HIV-1 protease preventing the cleavage of the gag-pol polyprotein resulting in the production of noninfectious virus.

Note

Nelvir 150mg Tablet manufactured by Cipla Ltd.. Its generic name is Nelfinavir. Nelvir is availble in Nepal. Farmaco Nepal drug index information on Nelvir Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Nelfinavir :